Evidence map›Paper›PMID 33576794›Full record

ArticleInvestigative ophthalmology & visual science2021

Molecular Epidemiology in 591 Italian Probands With Nonsyndromic Retinitis Pigmentosa and Usher Syndrome.

Leonardo Colombo, Paolo E Maltese, Marco Castori, Said El Shamieh, Christina Zeitz, Isabelle Audo, Alessandra Zulian, Carla Marinelli, Sabrina Benedetti, Alisia Costantini and 6 more

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Retinal Dystrophies Associated with Mutations in theCurrent issues in molecular biology · 2025
    Article
  16. Article
  17. Article
  18. Review
  19. Genes · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Leonardo ColomboDepartment of Ophthalmology, ASST Santi Paolo e Carlo Hospital, University of Milan, Milan, Italy.
Paolo E MalteseMAGI's Lab s.r.l., Rovereto, Italy.
Marco CastoriDivision of Medical Genetics, Fondazione IRCCS-Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Said El ShamiehDepartment of Medical Laboratory Technology, Faculty of Health Sciences, Beirut Arab University, Beirut, Lebanon.
Christina ZeitzSorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
Isabelle AudoSorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
Alessandra ZulianMAGI's Lab s.r.l., Rovereto, Italy.
Carla MarinelliMAGI's Lab s.r.l., Rovereto, Italy.
Sabrina BenedettiMAGI's Lab s.r.l., Rovereto, Italy.
Alisia CostantiniMAGI's Lab s.r.l., Rovereto, Italy.
Simone BressanMAGI's Lab s.r.l., Rovereto, Italy.
Marcella PercioMAGI's Lab s.r.l., Rovereto, Italy.
Paolo FerriDepartment of Ophthalmology, ASST Santi Paolo e Carlo Hospital, University of Milan, Milan, Italy.
Andi AbeshiMAGI's Lab s.r.l., Rovereto, Italy.
Matteo BertelliMAGI's Lab s.r.l., Rovereto, Italy.
Luca RossettiDepartment of Ophthalmology, ASST Santi Paolo e Carlo Hospital, University of Milan, Milan, Italy.
Center for Neuroscience and Cognitive Systems · ITInserm · FROspedale San Paolo · ITCasa Sollievo della Sofferenza · ITPoliclinico S.Orsola-Malpighi · ITSorbonne Université · FRUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To describe the molecular epidemiology of nonsyndromic retinitis pigmentosa (RP) and Usher syndrome (US) in Italian patients. Methods: A total of 591 probands (315 with family history and 276 sporadics) were analyzed. For 155 of them, we performed a family segregation study, considering a total of 382 relatives. Probands were analyzed by a customized multigene panel approach. Sanger sequencing was used to validate all genetic variants and to perform family segregation studies. Copy number variants of selected genes were analyzed by multiplex ligation-dependent probe amplification. Four patients who tested negative to targeted next-generation sequencing analysis underwent clinical exome sequencing. Results: The mean diagnostic yield of molecular testing among patients with a family history of retinal disorders was 55.2% while the diagnostic yield including sporadic cases was 37.4%. We found 468 potentially pathogenic variants, 147 of which were unpublished, in 308 probands and 66 relatives. Mean ages of onset of the different classes of RP were autosomal dominant RP, 19.3 ± 12.6 years; autosomal recessive RP, 23.2 ± 16.6 years; X-linked RP, 13.9 ± 9.9 years; and Usher syndrome, 18.9 ± 9.5 years. We reported potential new genotype-phenotype correlations in three probands, two revealed by TruSight One testing. All three probands showed isolated RP caused by biallelic variants in genes usually associated with syndromes such as PERCHING and Senior-Loken or with retinal dystrophy, iris coloboma, and comedogenic acne syndrome. Conclusions: This is the largest molecular study of Italian patients with RP in the literature, thus reflecting the epidemiology of the disease in Italy with reasonable accuracy.

Indexed as

MutationAdolescentAdultAgedAged, 80 and overChildDNA Mutational AnalysisExome SequencingExtracellular Matrix ProteinsFemaleFollow-Up StudiesGenetic Association StudiesGenetic TestingHumansIncidenceItalyExtracellular Matrix Proteins

Identifiers

PMID33576794
PMCPMC7884295
OpenAlexW3126878927

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.